Global Disease Outbreaks: A 2025 Snapshot and Implications for the U.S.
Each year, there are multiple infectious disease outbreaks (defined as the occurrence of cases of disease in excess of what is expected) throughout the world. Some of these become severe and have global and domestic implications, including, most notably, the COVID-19 pandemic, but also the 2002-2004 SARS outbreak in China and eventually 28 other countries and the 2014 Ebola outbreak in West Africa. Since outbreaks are an ongoing reality and threat to human health, understanding the current status and scope of global disease outbreaks is important for stemming further spread to other geographic areas and populations, providing advice to travelers, and identifying the types of medical countermeasures that might be needed. While historically the U.S. government has played a key and often lead role in responding to outbreaks throughout the world, particularly in low- and middle-income countries, understanding the extent of outbreaks takes on added importance now, given changes made by the Trump administration. These changes include reduced funding, reductions in the number of U.S. staff supporting international outbreak response efforts, and elimination of some offices and functions, actions which collectively have diminished current U.S. government capacity to respond to outbreaks at home and abroad, even as experts believe another costly pandemic may strike the world within 25 years. There may a renewed opportunity, however, to mitigate some of these risks with the release of the State Department’s new U.S. global health strategy, which includes global health security as one of its three pillars.
To better understand the current outbreak landscape around the world, and because there is no single database of all global outbreaks, we analyzed data from multiple official sources to develop a snapshot of the number, type, and location of disease outbreaks, with human transmission, that have occurred thus far in 2025. Based on this analysis, we identified more than 100 outbreaks, including some that have affected multiple countries and impacted large populations. This finding is broadly similar to an estimate from a prior study of the 1996-2023 period that identified an average of 108 outbreaks that occurred each year. However, given that 2025 is not yet over, there could be more outbreaks in the weeks and months ahead. Our finding is also likely an underestimate due to delays in reporting and other factors (see methods for more information).
Findings
Our analysis finds that thus far in 2025 (see Table 1):
- We identified 102 reported disease outbreaks with human transmission in 66 countries as of October 10, 2025; this is likely an undercount due to delays in reporting, the multiplicity of outbreaks that may be captured in this analysis as a single outbreak (e.g., the United States has identified 44 distinct outbreaks of measles as of Oct. 7 this year), and other factors.
- These outbreaks are due to 20 different infectious diseases spanning a wide variety of disease types (including respiratory, vector-borne, food or waterborne, and direct contact infections) and including avian influenza (H5N1), Chikungunya, cholera, Ebola, Marburg, measles, mpox, Nipah, Rift Valley fever, yellow fever, and Zika, among others.
- There is significant geographic variation in the occurrence of outbreaks by region. The greatest number of reported outbreaks have been in sub-Saharan Africa (33 countries), followed by the Western Hemisphere (15), East Asia and the Pacific (7), South and Central Asia (6), and the Near East (Middle East and North Africa, 5).
- A third of these countries (23) countries have experienced more than one outbreak this year, often of varying scales. For example, the Democratic Republic of the Congo has reported outbreaks of anthrax, cholera, cVDPV1, Ebola virus disease, mpox, and one outbreak due to an unexplained cause but described now as “acute febrile illness,” and the United States has reported outbreaks of dengue – which is not endemic in the continental U.S. but has caused localized transmission from travel-related imported cases – and measles, which had long been considered eliminated in the U.S., a status that is now at risk due to increasing cases.
- Outbreaks have ranged in size, as measured by number of cases as well as the number of affected countries. For example, a single case of Chapare hemorrhagic fever constituted an outbreak in Bolivia, while the largest this year has been the cholera outbreak across 34 countries, which has approached a half million cases and been declared a health emergency by the World Health Organization.
- Similarly, the number of deaths resulting from these outbreaks has also varied widely, as some virulent infectious diseases have led to high mortality, such as deaths among all suspected cases of Marburg virus disease (10 of 10) and deaths among two-thirds of suspected cases of Ebola virus disease (43 of 64). Others have resulted in few deaths but spread rapidly and can have important health impacts, such as chikungunya and mpox.
Table 1
Disease Outbreaks, 2025
| Disease | Country | Region* | Primary Category for Disease/Transmission | Number of Cases/Deaths (as of date) |
| Acute febrile illness | Democratic Republic of the Congo | Sub-Saharan Africa | Not applicable | 1,318 suspected cases, inc. 53 deaths (as of Feb. 25) |
| Anthrax | Democratic Republic of the Congo | Sub-Saharan Africa | Direct contact infection | 17 suspected cases, inc. 1 death (as of April 30) |
| Thailand | East Asia and the Pacific | 5 confirmed cases, inc. 1 death (as of May 28) | ||
| Uganda | Sub-Saharan Africa | 15 confirmed cases, inc. 2 deaths (as of March 30) | ||
| Avian Influenza | Cambodia | East Asia and the Pacific | Respiratory infection | Cambodia: 11 confirmed cases, inc. 6 deaths (as of July 1) Mexico: 1 confirmed case, inc. 1 death (as of April 2) |
| Mexico | Western Hemisphere | |||
| Chapare hemorrhagic fever | Bolivia | Western Hemisphere | Direct contact infection | 1 confirmed case, inc. 1 death (as of Jan. 13) |
| Chikungunya | Key countries: Bangladesh | South and Central Asia | Vector-borne infection | Global overview: 445,271 (263,592 suspected and 181,679 confirmed) cases, inc. 155 deaths (as of Sept. 30) Indian Ocean countries: data not provided (as of Sept. 5) Bolivia: data not provided (as of June 26) Cuba: data not provided (as of Sept. 26) La Réunion and Mayotte (France): in La Réunion, over 47,500 confirmed cases, but more than 170,000 consultations for suspected chikungunya, and at least 12 deaths, with more suspected; in Mayotte, 116 cases (as of May 4) |
| Bolivia | Western Hemisphere | |||
| China | East Asia and the Pacific | |||
| Cuba | Western Hemisphere | |||
| Kenya | Sub-Saharan Africa | |||
| La Réunion and Mayotte (France) | Sub-Saharan Africa | |||
| Madagascar | Sub-Saharan Africa | |||
| Somalia | Sub-Saharan Africa | |||
| Sri Lanka | South and Central Asia | |||
| Cholera | Afghanistan | South and Central Asia | Food-/waterborne infection | Global overview: 489,452 cholera/Acute Watery Diarrhea cases; 6,155 deaths (as of Sept. 26; earlier alert) |
| Angola | Sub-Saharan Africa | |||
| Bangladesh | South and Central Asia | |||
| Burundi | Sub-Saharan Africa | |||
| Chad | Sub-Saharan Africa | |||
| Cote d’Ivoire | Sub-Saharan Africa | |||
| Democratic Republic of the Congo | Sub-Saharan Africa | |||
| Ethiopia | Sub-Saharan Africa | |||
| Ghana | Sub-Saharan Africa | |||
| Haiti | Western Hemisphere | |||
| India | South and Central Asia | |||
| Iraq | Near East | |||
| Kenya | Sub-Saharan Africa | |||
| Malawi | Sub-Saharan Africa | |||
| Mozambique | Sub-Saharan Africa | |||
| Myanmar | East Asia and the Pacific | |||
| Namibia | Sub-Saharan Africa | |||
| Nepal | South and Central Asia | |||
| Niger | Sub-Saharan Africa | |||
| Nigeria | Sub-Saharan Africa | |||
| Pakistan | South and Central Asia | |||
| Philippines | East Asia and the Pacific | |||
| Republic of the Congo | Sub-Saharan Africa | |||
| Rwanda | Sub-Saharan Africa | |||
| Somalia | Sub-Saharan Africa | |||
| South Sudan | Sub-Saharan Africa | |||
| Sudan | Sub-Saharan Africa | |||
| Tanzania | Sub-Saharan Africa | |||
| Thailand | East Asia and the Pacific | |||
| Togo | Sub-Saharan Africa | |||
| Uganda | Sub-Saharan Africa | |||
| Yemen | Near East | |||
| Zambia | Sub-Saharan Africa | |||
| Zimbabwe | Sub-Saharan Africa | |||
| Dengue | United States of America | Western Hemisphere | Vector-borne infection | Outbreaks in various areas (as of July 29); 2,560 locally acquired cases (as of Sept. 25) |
| Ebola virus disease (EVD) (inc. Sudan virus disease, SVD) | Democratic Republic of the Congo Uganda | Sub-Saharan Africa | Direct contact infection | EVD: 64 suspected (53 confirmed and 11 probable) cases, inc. 43 deaths (as of Oct. 5; earlier alert) SVD: 14 cases – 12 confirmed, 2 probable – inc. 4 deaths – 2 confirmed, 2 probable (as of April 26) |
| Invasive meningococcal disease | Saudi Arabia | Near East | Direct contact infection | 17 cases (as of April 11) |
| Marburg virus disease | Tanzania | Sub-Saharan Africa | Direct contact infection | 10 suspected (2 confirmed, 8 probable) cases, inc. 10 deaths (as of March 12) |
| Measles | Argentina | Western Hemisphere | Respiratory infection | Region of the Americas (inc. United States of America): 10,139 confirmed cases, inc. 18 deaths (as of Aug. 8; earlier alert) Morocco: more than 25,000 suspected cases, inc. 13,706 confirmed cases and 184 deaths, from Oct. 2023 through April 13, 2025 (as of May 13) United States of America: 1,544 cases, inc. 3 deaths (as of Sept. 30) |
| Belize | Western Hemisphere | |||
| Bolivia | Western Hemisphere | |||
| Brazil | Western Hemisphere | |||
| Canada | Western Hemisphere | |||
| Costa Rica | Western Hemisphere | |||
| Mexico | Western Hemisphere | |||
| Morocco | Near East | |||
| Paraguay | Western Hemisphere | |||
| Peru | Western Hemisphere | |||
| United States of America | Western Hemisphere | |||
| Middle East respiratory syndrome (MERS) coronavirus | Saudi Arabia | Near East | Respiratory infection | 9 confirmed cases, inc. 2 deaths (as of April 21) |
| Mpox | Key countries: Burundi Democratic Republic of the Congo Kenya Rwanda Sierra Leone Uganda | Sub-Saharan Africa | Direct contact infection | Global overview: 38,671 confirmed cases, inc. 163 deaths (as of Aug. 31; earlier alert) |
| Nipah virus | Bangladesh India | South and Central Asia | Direct contact infection | Bangladesh: 4 confirmed cases, inc. 4 deaths (as of Aug. 29) India: 4 confirmed cases, inc. 2 deaths (as of July 12) |
| Oropouche virus disease | Key countries: Brazil Panama | Western Hemisphere | Vector-borne infection | Data not provided (as of July 14); Americas Region overview: 12,786 confirmed cases (as of July 27) |
| Rabies | Timor-Leste | East Asia and the Pacific | Direct contact infection | 4 confirmed cases, inc. 4 deaths (as of June 17) |
| Rift Valley Fever | Senegal | Sub-Saharan Africa | Vector-borne infection | Data not provided (as of Oct. 10) |
| Variant Poliovirus (i.e., circulating vaccine-derived poliovirus of three types: cVDPV1, cVDPV2, cVDPV3) | cVDPV1: Algeria | Near East | Food-/waterborne infection | cVDPV1 global overview: 2 cases of acute flaccid paralysis (as of Oct. 6) cVDPV2 global overview: 146 cases of acute flaccid paralysis (as of Oct. 6) cVDPV3 global overview: 5 cases of acute flaccid paralysis (as of Oct. 6) |
| Democratic Republic of the Congo | Sub-Saharan Africa | |||
| cVDPV2: Angola | Sub-Saharan Africa | |||
| Benin | Sub-Saharan Africa | |||
| Burkina Faso | Sub-Saharan Africa | |||
| Central African Republic | Sub-Saharan Africa | |||
| Chad | Sub-Saharan Africa | |||
| Djibouti | Sub-Saharan Africa | |||
| Ethiopia | Sub-Saharan Africa | |||
| Niger | Sub-Saharan Africa | |||
| Nigeria | Sub-Saharan Africa | |||
| Papua New Guinea | East Asia and the Pacific | |||
| Somalia | Sub-Saharan Africa | |||
| Sudan | Sub-Saharan Africa | |||
| Yemen | Near East | |||
| cVDPV3: Cameroon | Sub-Saharan Africa | |||
| Chad | Sub-Saharan Africa | |||
| Guinea | Sub-Saharan Africa | |||
| Yellow fever | Bolivia Brazil Colombia Ecuador Peru | Western Hemisphere | Vector-borne infection | 235 confirmed cases, inc. 96 deaths (as of May 25; earlier alert) |
| Zika virus disease | India | South and Central Asia | Vector-borne infection | 151 cases in 2024 (as of Jan. 29) |
| Note: * Regions reflect those used by the U.S. State Department; Near East includes the Middle East and North Africa. Disease outbreaks as identified and defined by the following authoritative sources: WHO, CDC, and GPEI; not an exhaustive list of outbreaks globally. As of Oct. 10, 2025. Does not include diseases such as COVID-19, wild poliovirus, and seasonal influenza where there have not been unexpected levels of cases and deaths this year. Sources: WHO, Disease Outbreak News, Situation Reports, and Rapid Risk Assessment Reports; CDC, Outbreak webpage; CDC, Travel Notices webpage; GPEI, Polio This Week. | ||||
Methods
This analysis is based on data from the World Health Organization (WHO: Disease Outbreak News, Situation Reports, and Rapid Risk Assessment Reports); U.S. Centers for Disease Control and Prevention (CDC: Outbreak webpage and Travel Notices webpage), and the Global Polio Eradication Initiative (GPEI: Polio This Week), with some supplementary data obtained from the Pan American Health Organization (PAHO). Case reports and data from these sources were used to identify outbreaks with human transmission (including transmission from animal to human) by country and type as of October 10, 2025. This estimate should be considered a floor. First, one or more outbreaks of a single disease reported in a particular country are counted as a single outbreak – for example, the United States has identified 44 distinct outbreaks of measles as of Oct. 7 this year, but it is included as a single outbreak in this analysis. Second, due to delays in reporting and non-reporting (due to capacity or other issues), not all outbreaks that have occurred have necessarily been reported to these sources. Third, not included in this analysis are diseases that may be significant and with ongoing transmission, including this year, but not reported to be occurring at unexpected levels, such as COVID-19, seasonal influenza, and wild poliovirus; also not included are diseases that are spreading among animals without transmission to humans. Finally, while the sources used are the main international sources available for tracking outbreaks, there may be other sources that capture additional data (such as ProMED from the International Society for Infectious Diseases, BEACON based at Boston University, and The Tracking Report based at Brown University).